Signal Ring Turns Your Finger Into a Blood-Pressure Dashboard, Minus the Cuff Drama
Signal Ring puts cuffless blood-pressure tracking on your finger for $399. It is focused, clever, and still waiting to prove the medical promise.
The blood-pressure cuff has spent 150 years perfecting one particular user experience: inflate a rubber band around your arm until you briefly regret having arteries, then stare at a number that may or may not represent the rest of your day.
Vital Signals would like to replace that ritual with a titanium ring. Signal Ring, announced on July 16, is a $399 smart ring that claims to measure blood pressure from your finger continuously, without a cuff and without the recurring calibration that makes other cuffless wearables feel like homework assigned by a vascular specialist. Preorders are open now. The sizing kit is expected this month; the ring and charging case are expected to ship in October.
I have not worn one yet, because time is real and preorders are not hands-on reviews. But as launches go, this is unusually legible. Signal Ring is not trying to remember your thoughts, coach your breathing, summarize your meetings, or become a tiny emotionally available roommate. It has one job: make blood pressure less annoying to measure. I mean that as both a joke and a compliment.
The Wearable Market Finally Remembers the “Health” Part
Most smart rings are wellness dashboards with excellent sleep guilt. Signal Ring is built around a harder problem: actual systolic and diastolic blood-pressure numbers, not merely an alert that your body may be doing something suspicious.
That distinction matters. Apple Watch and Oura can flag signs associated with hypertension, while some other wearables provide readings only after you calibrate them against a traditional cuff. Signal Ring’s pitch is that its high-speed optical sensor reads the pulse wave in more detail and uses algorithms to separate changes in arterial tone from changes in blood pressure itself. The company says that means every reading is built from scratch, with no baseline cuff required.
In other words, Vital Signals is selling the plumbing. Not a glowing ring that whispers “optimize,” but a persistent measurement system that might show how coffee, exercise, stress, meals, sleep, and the rest of your daily biochemical improv affect your numbers. That is a much better use of a wearable than telling me I had an “unproductive” afternoon because I sat down.
The company says the technology was tested on thousands of subjects and validated in a 451-person, multi-site clinical study against ISO 81060-2 requirements for blood-pressure cuffs. That is promising. It is also still a company statement attached to a product that has not been independently tested by reviewers or cleared by the FDA. The distinction is not a footnote; it is the entire plot.
Zen Mode Is Meditation With a Systolic Number
Signal Ring has an on-demand mode called “Zen Mode,” which guides you through posture cues, slow breathing, calming sound, and animation before taking a reading. This is either thoughtful design or the inevitable moment when every medical device becomes a wellness retreat.
Actually, it is thoughtful. Blood pressure is affected by context, and a rushed, badly positioned measurement can tell a story about the measurement more than the person. A guided reading gives the user a repeatable ritual instead of a tiny sensor that confidently dumps a number into an app while you are carrying groceries. The system also lets you add context to readings, so “125/78 after coffee and a brisk walk” does not masquerade as the same event as “125/78 while sitting quietly.”
The app is available on iOS and Android, connects over Bluetooth LE, and requires your phone to be nearby for readings to sync. The ring comes in sizes 5 through 13, has a titanium outer surface, a resin inner surface, an IP68 rating, and a three-day battery according to launch coverage. The charging case holds four charges. None of this is revolutionary, but that may be the point. Vital Signals appears to have spent the innovation budget on the sensor and algorithms instead of adding a screen to a ring, which would have been a magnificent way to lose the plot.
$399 Is Expensive Until You Compare It With Avoiding the Cuff
At $399, Signal Ring costs roughly what premium smart rings already cost, except it is not primarily competing on sleep scores or readiness graphs. It is asking people with hypertension risk, cardiovascular concerns, or a doctor-shaped reason to monitor blood pressure to pay a premium for convenience and trend visibility.
There is no subscription. This is quietly radical in a category that has developed the habit of charging rent for your own body data. The company says it makes money by selling the ring, not by selling personal information, and the app features are included. Data can be exported, and Vital Signals says it is not adding AI. You may now consult the AI of your choice, which is a pleasingly adult arrangement: the company sells you a sensor and declines to put a chatbot in your bloodstream.
The catch is that $399 buys a promise today and a product later. Preorders are refundable within 30 days of receiving the ring, minus a $25 handling fee for the sizing kit. The device is U.S.-only, ships in October, and is explicitly not a medical device.
That makes the buyer profile narrow. If you are young, healthy, and mostly want sleep and recovery tracking, Pebble’s simpler smart-ring philosophy is more charming, cheaper, and less likely to make you wonder whether your lunch requires clinical interpretation. If you want broad wellness metrics, you probably already know the established players. Signal Ring is for the person who owns a cuff, dislikes using it, and has a real reason to care about patterns over time.
The Ring Is Smart. The Category Is Still Wearing a Lab Coat.
I like the focus here. The hardware is deliberately boring. The company is not pretending that blood pressure needs a social feed, a digital coach, or an ambient personality. That restraint puts it in the same family as Google’s screenless Fitbit gamble, but with a sharper reason to remove the screen: the ring should not become another tiny rectangle demanding attention.
It also sits in the increasingly crowded line of wearables that want to turn private physiology into a continuous story. Lumia’s blood-flow-tracking earrings pushed the same logic toward the ear, where jewelry apparently now doubles as a circulatory spreadsheet. Signal Ring is less glamorous and more immediately understandable. Finger, pulse, number. The body remains strange, but at least the product diagram fits on one slide.
The awkwardness is that the product’s credibility depends on evidence most consumers cannot personally inspect. You can compare sleep graphs. You can hear whether headphones sound good. You cannot casually validate a new blood-pressure algorithm while waiting for a sandwich. The demo is never the hard part. The hard part is showing that readings stay accurate across different bodies, skin tones, movement, temperatures, ring fits, and ordinary human chaos.
That is why the FDA disclaimer matters. The company’s consumer messaging is confident—“No cuff. Ever.”—while its safety language is appropriately cautious. Both can be true. Signal Ring may be a meaningful monitoring tool and still not be something you use to diagnose yourself or change medication. Consult a clinician rather than letting a $399 ring become your new doctor, priest, and numerically judgmental friend.
Verdict: A Focused Bet, Not Yet a Mass-Market Hit
Signal Ring feels less like a mass-market consumer hit than a beautifully targeted flex: expensive, specialized, and potentially transformative for exactly the people who hate the conventional solution. The no-subscription model is smart. The phone app, guided readings, context, and exportable data are sensible. The lack of AI is almost suspiciously refreshing.
But the core promise remains the sort of thing that needs independent testing, regulatory progress, and a lot of boring real-world data before I would call it a breakthrough. Until then, it is a compelling preorder for a specific user and a speculative purchase for everyone else.
I am more impressed than annoyed, which is rare enough to record. Signal Ring is trying to make an important health signal easier to see without turning the experience into a subscription funnel or an AI séance. If the accuracy holds up, Vital Signals may have built the first smart ring whose most valuable feature is not what it adds to your life, but the miserable medical ritual it lets you avoid.
That is a niche flex. It is also, annoyingly, a good one. As we learned from Cash App turning payment hardware into a wearable object, the best consumer gadgets often win by fitting into a behavior you already have. Signal Ring’s behavior is less fun than tapping a magic wand at a coffee shop. It is also more important.